We are proposing various businesses, such as the establishment and proposal of new drug development-related supporting policies and systems, regulation improvement, national R&D business plans, construction of cooperation and open innovation environment between internal and external industry?academic ventures, infra creation for R&D support, international investigations for sustainability management of R&D-centered pharmaceutical industry, and strengthening of global innovative capability.